1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Bronchial Neoplasms in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Bronchial Neoplasms: Tumors or cancer of the BRONCHI.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albright, CD | 1 |
Grimley, PM | 1 |
Jones, RT | 1 |
Fontana, JA | 1 |
Keenan, KP | 1 |
Resau, JH | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Bronchial Neoplasms
Article | Year |
---|---|
Cell-to-cell communication: a differential response to TGF-beta in normal and transformed (BEAS-2B) human bronchial epithelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bronchi; Bronchial Neoplasms; Calmodulin; Cell Commun | 1991 |